Clinical Trial Update: A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2b/3a trial evaluating JointStem for knee osteoarthritis is ongoing and currently recruiting. The sponsor is Nature Cell Co. Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• JointStem

Snippet

Sponsor: Nature Cell Co. Ltd. | Conditions: Osteoarthritis, Knee | Phase 2, Phase 3 | Status: RECRUITING